Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bronchodilator therapy for chronic obstructive pulmonary disease

C C Lu1

  • 1Chest Department, Division of Clinical Pulmonary Physiology, Veterans General Hospital-Taipei, Taiwan.

Respirology (Carlton, Vic.)
|April 3, 1998
PubMed
Summary

Bronchodilator therapy, including beta2-agonists and ipratropium bromide, helps manage chronic obstructive pulmonary disease (COPD) symptoms. Combining these agents and optimizing inhalation techniques can improve efficacy and reduce side effects in COPD patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Application of cloud-based information platform in China National Birth Cohort].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2021
Same author

Effect of different types of sugar on gut physiology and microbiota in overfed goose.

Poultry science·2021
Same author

Development and Validation of a Natural Language Processing Tool to Identify Patients Treated for Pneumonia across VA Emergency Departments.

Applied clinical informatics·2018
Same author

[Expression and intratumoral heterogeneity of LN-5γ2 in esophageal squamous cell carcinoma].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2016
Same author

Extreme Hyperlactatemia After Heart Transplantation: One Center's Experience.

Transplantation proceedings·2015
Same author

Gate length scaling effect on high-electron mobility transistors devices using AlGaN/GaN and AlInN/AlN/GaN heterostructures.

Journal of nanoscience and nanotechnology·2015

Area of Science:

  • Pulmonology
  • Pharmacology

Background:

  • Chronic obstructive pulmonary disease (COPD) is a progressive respiratory condition marked by airflow limitation and bronchial hyperreactivity.
  • Bronchodilator therapy aims to alleviate symptoms, improve airway obstruction, and potentially slow disease progression in COPD patients.

Discussion:

  • In acute exacerbations, inhaled beta2-agonists are the primary treatment; the role of higher-dose anticholinergic inhalation is under investigation.
  • Theophylline offers chronic maintenance therapy and potential acute phase benefits, while sympathomimetics may lack sufficient bronchodilation.
  • Ipratropium bromide is a popular long-term bronchodilator, with combinations of ipratropium and beta2-agonists offering rapid onset and prolonged action with reduced side effects.

Key Insights:

  • Combined ipratropium and beta2-agonist therapy provides synergistic benefits in COPD management.

Related Experiment Videos

  • Proper inhalation techniques, including the use of spacers or nebulizers, are crucial for effective bronchodilator delivery, especially in severe cases.
  • Bronchodilator therapy manages COPD symptoms but does not prevent disease development or halt pulmonary function decline; comprehensive management is essential.

    • Outlook:

    • Further research into optimal dosing and combinations of bronchodilators for acute COPD exacerbations is warranted.
    • Improving patient inhalation technique through education and device selection is key to maximizing therapeutic benefits.
    • Integrating bronchodilator therapy within a broader COPD management strategy is critical for long-term patient outcomes.